CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 25,871 enrolled
Drug / intervention
Vitamin D and fish oil +3 moredrug
Likely dose
Vitamin D and fish oil 2000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02271230
NCT02271230Phase 3Completed
CompareCT.gov

Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure

Brigham and Women's Hospital·interventional·Posted Oct 22, 2014·Updated Mar 18, 2022

In Brief

A Phase 3 clinical trial evaluating Vitamin D and fish oil, Fish oil (EPA/DHA) alone, and 2 other interventions for Heart Failure. Completed, enrolled 25,871 participants across 1 site.

Detailed Summary

This study will examine whether an intervention with vitamin D or fish oil supplements can reduce the risk of heart failure among adult men and women during a follow up period of up to five years (starting from the time of randomization into the parent VITAL trial). The investigators hypotheses are that both vitamin D and fish oil supplements will each reduce the risk of heart failure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 22, 2014
Enrollment StartAug 1, 2014
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11.7 years ago

Interventions

Vitamin D and fish oildrug

2000 IU vitamin D and 1g/d fish oil

Fish oil (EPA/DHA) alonedietary

1 g/d fish oil

Vitamin D alonedrug

2000 IU vitamin D

Placeboother

Vitamin D placebo and fish oil placebo